| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/07/1996 | CN1116094A Preparation of nutrient heathful composition from 1,6-fructose diphosphate calcium salt or sodium salt |
| 02/07/1996 | CN1116065A Yizaojing (extract of ant and jujube) |
| 02/07/1996 | CN1030920C Process for making mometasone furoate monohydrate |
| 02/06/1996 | US5489615 Pharmaceutical ointment being free from skin irritative action and a process for the preparation thereof |
| 02/06/1996 | US5489610 Sustained release organic nitrite therapy |
| 02/06/1996 | US5489604 Treating degenerative diseases |
| 02/06/1996 | US5489577 Stabilized proteinaceous bioactive substance prepared by mixing with an oligosaccharide and kneading with an oil or fat base; ease of administration |
| 02/06/1996 | US5489439 Granular pharmaceutical formulations |
| 02/06/1996 | US5489436 Taste mask coatings for preparation of chewable pharmaceutical tablets |
| 02/06/1996 | US5489435 Composition for treatment of abnormal conditions of the epithelium of bodily orifices |
| 02/06/1996 | US5489426 Cosmetic composition based on an aqueous dispersion of small lipid spheres |
| 02/06/1996 | US5489401 Method for entrapment of active materials in chitosan |
| 02/06/1996 | US5489279 Method of applying photodynamic therapy to dermal lesion |
| 02/04/1996 | CA2155170A1 Stably storable and readily water soluble composition of cephalosporin for injections |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002609A1 Antioxidant-containing blowing agent |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002554A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | WO1996002491A1 Positive photoactive compounds based on 2,6-dinitrobenzyl groups |
| 02/01/1996 | WO1996002488A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 02/01/1996 | WO1996002285A1 Alginate fibres, manufacture and use |
| 02/01/1996 | WO1996002284A1 Alginate fibre, process for the preparation thereof and use |
| 02/01/1996 | WO1996002283A1 Alginate fibres, method of preparation and use |
| 02/01/1996 | WO1996002278A1 Immunonanoparticles coated with anti-beta-2 microglobulin monoclonal antibodies |
| 02/01/1996 | WO1996002276A2 Novel polymer gel networks and methods of use |
| 02/01/1996 | WO1996002275A1 Sustained-release oral ointment |
| 02/01/1996 | WO1996002261A1 Use of magnesium hydroxide as a stool softener |
| 02/01/1996 | WO1996002247A1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 02/01/1996 | WO1996002239A2 Enhanced loading of solutes into polymer gels and methods of use |
| 02/01/1996 | WO1996002238A1 Neurotropic and sedative agent and a method of obtaining the same |
| 02/01/1996 | WO1996002237A1 Novel method for preparing dry pharmaceuticals capable of virtually instantaneous disintegration, and resulting pharmaceuticals |
| 02/01/1996 | WO1996002236A1 Improved combination dose unit |
| 02/01/1996 | WO1996002235A1 Injectable res avoiding inorganic particles |
| 02/01/1996 | WO1996002234A1 Self-desintegrating compact granules used in galenic forms and containing active insoluble or hardly soluble principles |
| 02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
| 02/01/1996 | WO1996002232A1 Composition and method for enhancing transdermal electrotransport agent delivery |
| 02/01/1996 | WO1996002231A1 Inhalation composition |
| 02/01/1996 | WO1995035112A3 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 02/01/1996 | WO1995026739A3 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions |
| 02/01/1996 | DE4430449C1 Versprühbare filmbildende Wirkstoffabgabesysteme zur Anwendung an Pflanzen Sprayable film-forming drug delivery systems for use on plants |
| 02/01/1996 | DE4427821A1 Stabilised super-paramagnetic aggregate particles |
| 02/01/1996 | DE4426396A1 Verfahren zur Herstellung konzentrierter Lösungen von mikroverkapselten Zellen oder von suspendierten Wirkstoffen in mikroverkapselter Form A process for the preparation of concentrated solutions of microencapsulated cells or of suspended substances in microencapsulated form |
| 02/01/1996 | DE19527140A1 Sprühbare Lösungen mit blutdrucksenkender Wirkung und Verfahren zu ihrer Herstellung sowie ihre Verwendung Sprayable solutions with antihypertensive effect and process for their preparation and their use |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195091A1 Dinucleoside-5',5'-pyrophosphates |
| 01/31/1996 | EP0694310A1 Reversible, thermally gelling water-base medicinal composition |
| 01/31/1996 | EP0694308A1 Cyclosporin-containing emulsion composition |
| 01/31/1996 | EP0694300A1 Treatment of impotence |
| 01/31/1996 | EP0694299A1 The use of( a) bicycloheptane derivative(s) |
| 01/31/1996 | EP0693963A1 Use of a transacylation reaction between an esterified polysaccharide and a polyamine to form a membrane at least on the surface of gelled particles in an aqueous medium, resulting particles, preparation methods therefor and compositions containing same |
| 01/31/1996 | EP0693935A1 Method and compositions for digesting tissue |
| 01/31/1996 | EP0693932A1 Methods and compositions for inducing phase separation of epithelial lipid bilayers |
| 01/31/1996 | EP0693929A1 Method for preventing keratocyte loss |
| 01/31/1996 | EP0693926A1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 01/31/1996 | EP0693924A1 METHODS FOR $i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR |
| 01/31/1996 | EP0693923A1 Method for making a bioerodible material for the substained release of a medicament and the material made from the method |
| 01/31/1996 | EP0693922A1 Pharmaceutical composition containing lipophilic drugs |
| 01/31/1996 | EP0693921A1 Anti-oxidant alkylaryl polyether alcohol polymers |
| 01/31/1996 | EP0693884A1 Encapsulation compositions |
| 01/31/1996 | EP0693878A1 Iodine barrier teat dip |
| 01/31/1996 | EP0617611B1 Oral osmotic device |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | EP0502119B1 Lipospheres for controlled delivery of substances |
| 01/31/1996 | EP0495918B1 Amino acid beta-lyase enzyme inhibitors as deodorants |
| 01/31/1996 | CN1115980A Dehydrogenation process |
| 01/31/1996 | CN1115979A New crystalline form of vitamin D analogue |
| 01/31/1996 | CN1115964A Percutaneously absorbable preparation |
| 01/31/1996 | CN1115667A Antidiarrheal medicine |
| 01/31/1996 | CN1115665A Chinese medicine capsule for giving up drugging |
| 01/31/1996 | CN1115662A Drug for acne and its prepn |
| 01/31/1996 | CN1115659A Antiphlogistic liquid |
| 01/31/1996 | CN1115657A Physique-strengthening wind-dispelling plaster |
| 01/31/1996 | CN1115656A Inhalant volatile-oil composite, medicine core and relevant health article |
| 01/31/1996 | CN1115651A Gynostemma pentaphylla granule |
| 01/31/1996 | CN1115650A Buccal tablet for throat and its compounding |
| 01/31/1996 | CN1115649A Liver cancer-curing oral liquid prepared with white ant as main material |
| 01/31/1996 | CN1115645A Detumescent anodyne slurry |
| 01/31/1996 | CN1115641A Prepn of cyclopropyloxacini injecta |
| 01/31/1996 | CN1115639A Vaginal suppository of 0.25 mg compound stilbestrol |
| 01/31/1996 | CN1115638A External-use drug form |
| 01/31/1996 | CN1115634A Prepn of Chinese medicine oil-tincture mixture |
| 01/31/1996 | CN1115616A Health additive and products for smokers |
| 01/30/1996 | US5488075 Injectable fluid of maleic anhydride-styrene copolymer in dimethyl sulfoxide |
| 01/30/1996 | US5488069 Antiinflammatory agents for eyes |
| 01/30/1996 | US5488062 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/30/1996 | US5488034 Pharmaceutical composition comprising BPI proteins |
| 01/30/1996 | US5487916 Method for coating particles in a spray-drying plant |
| 01/30/1996 | US5487902 Chewing gum composition with accelerated, controlled release of active agents |
| 01/30/1996 | US5487901 Coating with impermeable polymeric film; removal of raised top layer by contacting abraded surface with environment |
| 01/30/1996 | US5487900 Stabilized vitamin D preparation |
| 01/30/1996 | US5487898 Compositions and method for the sublingual or buccal administration therapeutic agents |
| 01/30/1996 | US5487897 Thermoplastic polymer, in vivo coagulation, drug delivery, wound healing, tissue regeneration |
| 01/30/1996 | US5487895 Method for forming controlled release polymeric substrate |
| 01/30/1996 | US5487886 Amino acid β-lyase enzyme inhibitors as deodorants |
| 01/30/1996 | US5487739 Implantable therapy systems and methods |
| 01/30/1996 | US5487390 Gas-filled polymeric microbubbles for ultrasound imaging |
| 01/30/1996 | CA2055905C Pharmaceutical composition comprising calcium polycarbophil |
| 01/30/1996 | CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients |
| 01/30/1996 | CA2025078C External analgesic lotion and method of making |
| 01/30/1996 | CA1338009C Prolonged activity nicotine patch |